The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)
Official Title: Prospective Randomized Trial of the Effective Therapy for Small, Solitary HCC Comparing Operation and Percutaneous Ethanol Injection Therapy
Study ID: NCT00357422
Brief Summary: The purpose of this study is to choose the preferred treatment modality for solitary, small hepatocellular carcinoma.
Detailed Description: To compare the below things between operation group and percutaneous ethanol injection therapy (PEIT) group: 1. Survival * 5 year overall survival rate * Disease free survival rate 2. Recurrence * Cumulative recurrence rate
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Seoul NUH, Seoul, Chongno-gu, Korea, Republic of
Name: J H Yoon, Professor
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR